Evolent Health [EVH] vs Certara [CERT] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Evolent Health Inc. wins in 8 metrics, Certara Inc. wins in 10 metrics, with 1 ties. Certara Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Evolent Health Inc. | Certara Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.58 | 105.00 | Certara Inc. |
| Price-to-Book Ratio | 0.85 | 0.95 | Evolent Health Inc. |
| Debt-to-Equity Ratio | 238.37 | 28.96 | Certara Inc. |
| PEG Ratio | 0.00 | -0.53 | Tie |
| EV/EBITDA | 13.48 | 11.42 | Certara Inc. |
| Profit Margin (TTM) | -28.49% | -0.38% | Certara Inc. |
| Operating Margin (TTM) | -2.06% | 2.08% | Certara Inc. |
| EBITDA Margin (TTM) | N/A | 2.08% | N/A |
| Return on Equity | -66.54% | -0.15% | Certara Inc. |
| Return on Assets (TTM) | -0.13% | 0.93% | Certara Inc. |
| Free Cash Flow (TTM) | $4.76M | $69.77M | Certara Inc. |
| 1-Year Return | -41.96% | -52.77% | Evolent Health Inc. |
| Price-to-Sales Ratio (TTM) | 0.19 | 2.31 | Evolent Health Inc. |
| Enterprise Value | $1.19B | $1.12B | Evolent Health Inc. |
| EV/Revenue Ratio | 0.63 | 2.68 | Evolent Health Inc. |
| Gross Profit Margin (TTM) | 20.75% | 62.21% | Certara Inc. |
| Revenue per Share (TTM) | $16 | $3 | Evolent Health Inc. |
| Earnings per Share (Diluted) | $-5.07 | $-0.01 | Certara Inc. |
| Beta (Stock Volatility) | 0.37 | 1.62 | Evolent Health Inc. |
| Short % of Float | 14.47% | 22.71% | Evolent Health Inc. |
Evolent Health Inc. vs Certara Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Evolent Health Inc. | -2.08% | 0.86% | 18.69% | 55.63% | 14.08% | 20.82% |
| Certara Inc. | 0.19% | -0.19% | 16.29% | -19.72% | -40.39% | -40.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Evolent Health Inc. | -41.96% | -83.22% | -75.66% | -70.50% | -74.55% | -74.55% |
| Certara Inc. | -52.77% | -70.03% | -81.17% | -86.34% | -86.34% | -86.34% |
Performance & Financial Health Analysis: Evolent Health Inc. vs Certara Inc.
| Metric | EVH | CERT |
|---|---|---|
| Market Information | ||
| Market Cap | $329.33M | $969.01M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,779,287 | 2,754,263 |
| 90 Day Avg. Volume | 2,982,706 | 4,134,951 |
| Last Close | $4.70 | $5.21 |
| 52 Week Range | $2.10 - $12.06 | $4.45 - $13.88 |
| % from 52W High | -61.04% | -62.46% |
| All-Time High | $39.78 (Sep 12, 2022) | $45.48 (Nov 01, 2021) |
| % from All-Time High | -88.19% | -88.54% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.28% | 0.03% |
| Quarterly Earnings Growth | N/A | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.28% | 0.00% |
| Operating Margin (TTM) | -0.02% | 0.02% |
| Return on Equity (TTM) | -0.67% | 0.00% |
| Debt to Equity (MRQ) | 238.37 | 28.96 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.72 | $6.68 |
| Cash per Share (MRQ) | $1.36 | $1.19 |
| Operating Cash Flow (TTM) | $38.84M | $96.33M |
| Levered Free Cash Flow (TTM) | $98.41M | $96.40M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Evolent Health Inc. vs Certara Inc.
| Metric | EVH (Apr 24, 2026) | CERT (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.58 | 105.00 |
| Forward P/E | 7.13 | 12.87 |
| PEG Ratio | 0.00 | -0.53 |
| Price to Sales (TTM) | 0.19 | 2.31 |
| Price to Book (MRQ) | 0.85 | 0.95 |
| Market Capitalization | ||
| Market Capitalization | $329.33M | $969.01M |
| Enterprise Value | $1.19B | $1.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.63 | 2.68 |
| Enterprise to EBITDA | 13.48 | 11.42 |
| Risk & Other Metrics | ||
| Beta | 0.37 | 1.62 |
| Book Value per Share (MRQ) | $3.72 | $6.68 |
Financial Statements Comparison: Evolent Health Inc. vs Certara Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | EVH (2025) | CERT (2025) |
|---|---|---|
| Revenue/Sales | 1.88B | 418.84M |
| Cost of Goods Sold | 1.48B | 161.13M |
| COGS % of Revenue | 78.7% | 38.5% |
| Gross Profit | 399.88M | 257.71M |
| Gross Margin | 21.3% | 61.5% |
| Research & Development | N/A | 41.04M |
| Operating Income (EBIT) | -19.83M | 21.02M |
| Operating Margin | -1.1% | 5.0% |
| EBITDA | 85.02M | 102.52M |
| EBITDA Margin | 4.5% | 24.5% |
| Pre-Tax Income | -534.64M | 7.62M |
| Pre-Tax Income % of Revenue | -28.5% | 1.8% |
| Income Tax | -126,000 | 9.21M |
| Income Tax % of Revenue | 0.0% | 2.2% |
| Net Income (Profit) | -534.51M | -1.60M |
| Profit Margin | -28.5% | -0.4% |
Balance Sheet & Liquidity Metrics
| Metric | EVH (2025) | CERT (2025) |
|---|---|---|
| Cash & Equivalents | 151.86M | 189.39M |
| Total Current Assets | 506.37M | 315.12M |
| Total Current Assets % of Revenue | 27.0% | 75.2% |
| Total Current Liabilities | 385.26M | 153.39M |
| Total Current Liabilities % of Revenue | 20.5% | 36.6% |
| Long-Term Debt | 974.36M | 298.57M |
| Long-Term Debt % of Revenue | 51.9% | 71.3% |
| Total Shareholders Equity | 415.19M | 1.06B |
| Retained Earnings | -1.32B | -129.88M |
| Retained Earnings % of Revenue | -70.1% | -31.0% |
| Property, Plant & Equipment | 4.37M | 11.94M |
Cash Flow Statement Comparison
| Metric | EVH (2025) | CERT (2025) |
|---|---|---|
| Operating Cash Flow | -425.17M | 91.68M |
| Operating Cash Flow % of Revenue | -22.7% | 21.9% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | 4.76M | 69.77M |
| FCF Margin | 0.3% | 16.7% |
| Debt Repayment | -342.98M | -2.99M |
| Common Stock Repurchase | -40.00M | -42.61M |
Short Interest & Institutional Ownership Analysis
| Metric | EVH | CERT |
|---|---|---|
| Shares Short | 15.95M | 22.29M |
| Short Ratio | 5.14 | 5.09 |
| Short % of Float | 14.47% | 22.71% |
| Shares Outstanding | 111.63M | 159.14M |
| Float Shares | 92.79M | 109.20M |
| % Held by Insiders | 1.62% | 2.50% |
| % Held by Institutions | 110.52% | 116.00% |
| % Held by Public | -12.14% | -18.50% |
Dividend Analysis & Yield Comparison: Evolent Health Inc. vs Certara Inc.
| Metric | EVH | CERT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |